Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
302 studies found for:    "cyclic neutropenia" OR "Neutropenia"
Show Display Options
Rank Status Study
21 Unknown  Garlic in Patients With Febrile Neutropenia
Conditions: Chemotherapy;   Neutropenia
Interventions: Dietary Supplement: Solgar Israel;   Other: Placebo capsules
22 Unknown  Prevention of Neutropenia After Using G-CSF With TAC Chemotherapy
Condition: Neutropenia
Interventions: Drug: late leukostim;   Drug: early leukostim
23 Completed Comparison of the Pharmacodynamics of Imipenem in Patients With Febrile Neutropenia
Condition: Patients With Febrile Neutropenia
Intervention: Drug: Imipenem
24 Completed Safety, Tolerance and Pharmacokinetics of Anidulafungin in Immunocompromised Children Ages 2-17
Condition: Neutropenia
Intervention: Drug: Anidulafungin
25 Completed Meropenem Versus Meropenem Plus Glycopeptide in Patients With Febrile Neutropenia After Allogenic Blood Stem Cell Transplantation
Conditions: Allogenic Blood Stem Cell Transplantation;   Febrile Neutropenia
Interventions: Drug: Meropenem;   Drug: Vancomycin;   Drug: Teicoplanin
26 Unknown  International Registry for Severe Chronic Neutropenia
Condition: Neutropenia
Intervention:
27 Recruiting A Trial of MB-6 for Reduction of Neutropenia Induced by Chemotherapy in Patients With Stage III Colorectal Cancer.
Conditions: Stage III Colorectal Cancer;   Neutropenia
Interventions: Drug: MB-6;   Drug: Placebo
28 Completed Safety and Efficacy Study of GCSF Therapy to Treat Patients at High Risk for Chemotherapy Induced Severe Neutropenia
Conditions: Breast Cancer;   Neutropenia
Intervention: Drug: AVI-014 versus Filgrastim
29 Completed Dose Finding Study of KRN125 (Pegfilgrastim) for Treatment of Neutropenic Patients
Condition: Neutropenia
Intervention: Drug: pegfilgrastim
30 Recruiting RAnDomized Trial of SPI-2012 Versus Pegfilgrastim in the Management of Chemotherapy Induced Neutropenia in Breast CANCEr Patients Receiving Docetaxel and Cyclophosphamide
Conditions: Neutropenia;   Breast Cancer
Interventions: Drug: SPI-2012;   Drug: Pegfilgrastim
31 Not yet recruiting Trial of SPI-2012 Versus Pegfilgrastim in the Management of Chemotherapy Induced Neutropenia in Early- Stage BReast Cancer Patients Receiving Docetaxel and Cyclophosphamide (RECOVER)
Conditions: Neutropenia;   Breastcancer
Interventions: Drug: SPI-2012;   Drug: Pegfilgrastim;   Drug: Docetaxel;   Drug: Cyclophosphamide
32 Terminated Maintaining a Higher Level of Haemoglobin: Effect on the White Cells After Bone Marrow Transplantation in Children.
Condition: Neutropenia
Interventions: Other: Transfusion level 120 g/dL;   Other: Transfusion level 70 g/dL;   Other: Platelet transfusion
33 Terminated Peripheral Stem Cell Transplantation to Prevent Neutropenia in Patients Receiving Chemotherapy for Relapsed or Refractory Non-Hodgkin's Lymphoma
Conditions: Lymphoma;   Neutropenia
Interventions: Biological: epoetin alfa;   Biological: filgrastim;   Biological: recombinant flt3 ligand;   Biological: recombinant interleukin-3;   Biological: sargramostim;   Procedure: in vitro-treated peripheral blood stem cell transplantation
34 Completed
Has Results
AMD 3100 for Treatment of Myelokathexis
Condition: Neutropenia
Intervention: Drug: AMD3100 or plerixafor
35 Completed
Has Results
Study Investigating How Physicians Assess the Risk of Patients Developing Febrile Neutropenia During Chemotherapy.
Condition: Chemotherapy-induced Febrile Neutropenia
Intervention:
36 Recruiting Natural History Study for BEN
Condition: Neutropenia
Intervention:
37 Completed Anidulafungin in Treating Immunocompromised Children With Neutropenia
Conditions: Infection;   Neutropenia;   Unspecified Childhood Solid Tumor, Protocol Specific
Intervention: Drug: anidulafungin
38 Completed Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy
Condition: Neutropenia
Intervention: Drug: pegfilgrastim
39 Completed G-CSF in Preventing Neutropenia in Patients With Solid Tumors Who Are Receiving Chemotherapy
Conditions: Chemotherapeutic Agent Toxicity;   Neutropenia;   Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Biological: filgrastim
40 Recruiting Short Versus Extended Antibiotic Treatment With a Carbapenem for High-risk Febrile Neutropenia in Hematology Patients With FUO
Conditions: Febrile Neutropenia;   Hematological Malignancy
Intervention: Drug: Discontinuation of imipenem-cilastatin or meropenem

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.